ABBOTT NORTHWESTERN HOSPITAL
1. Target Overview & Investment Thesis
ABBOTT NORTHWESTERN HOSPITAL is a 586-bed large academic medical center in HENNEPIN, MN with $1.24B in net patient revenue and a -26.9% operating margin. The hospital serves a payer mix of 22.5% Medicare, 7.5% Medicaid, and 70.0% commercial.
Thesis: Undervalued. Our ML models identify $91.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -26.9% to -19.6% (+736bps).
| Net Revenue HCRIS | $1.24B |
| Current EBITDA COMPUTED | $-334.0M |
| Operating Margin COMPUTED | -26.9% |
| Occupancy HCRIS | 79.0% |
| Revenue / Bed COMPUTED | $2.1M |
| Net-to-Gross HCRIS | 32.4% |
| Distress Probability ML | 42.6% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -26.9% places it below the state median. Among 12 size-comparable peers (293-1172 beds), the median margin is -5.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (293-1172), prioritizing same-state peers. 12 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ABBOTT NORTHWESTERN HOSPITAL (Target) | MN | 586 | $1.24B | -26.9% |
| MAYO CLINIC HOSPITAL ROCHESTER | MN | 1157 | $3.45B | 31.8% |
| UNIVERSITY OF MINNESOTA MEDICA | MN | 634 | $1.84B | -18.1% |
| HENNEPIN COUNTY MEDICAL CENTER | MN | 335 | $1.19B | -11.2% |
| CHILDRENS HEALTH CARE | MN | 400 | $965.5M | -3.1% |
| ST. CLOUD HOSPITAL | MN | 458 | $943.6M | -1.7% |
| REGIONS HOSPITAL | MN | 423 | $862.7M | -7.6% |
| MERCY HOSPITAL | MN | 464 | $783.1M | -7.3% |
| UNITED HOSPITAL | MN | 362 | $762.9M | -10.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $91.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $26.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $24.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $24.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $15.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $794K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-334.0M |
| + RCM Uplift | +$91.3M |
| Pro Forma EBITDA | $-242.7M |
| Current Margin | -26.9% |
| Pro Forma Margin | -19.6% |
| WC Released (1x) | $47.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-513.8M | $-1.29B | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-513.8M | $-1.59B | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-462.4M | $-1.45B | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-462.4M | $-1.72B | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-565.2M | $-1.58B | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-565.2M | $-1.92B | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 12 hospitals with 293-1172 beds
- Same-state prioritization (n=13)
- Comp margins: P25=-10.3% / P50=-5.5% / P75=-2.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.